 trial, clopidogrel reduced the myocardial infarction,
stroke, or vascular death rate by 23.8% more than aspirin
alone.82 Although a single study demonstrated that combination aspirin and clopidogrel therapy was associated with a
20% relative risk reduction for myocardial infarction, cardiovascular death, or stroke,83 there is no evidence to date
that combination therapy is a more effective treatment for
PAD than a single agent,